|
National Stock Number(NSN): 6505-01-377-0468 (6505013770468, 013770468)
| NIIN: |
01-377-0468 |
Item Name: |
AZITHROMYCIN CAPSULES |
INC: |
48422
|
| FSC: |
6505
|
Assignment Date: |
Jul-02-1993 |
CRIT: |
X |
IIG: |
48422 |
| ISC: |
2 |
Date Standardized: |
Jul-02-1993 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Jun-01-1998 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-449-1618 |
Item Name: |
AZITHROMYCIN TABLETS |
| FSC: |
6505 |
Replacement Date: |
Jun-01-1998 |
|
INC: |
68970 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
L93-249 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00069-3050-34 |
2F027
|
PFIZER LABORATORIES DIV OF PFIZER INC |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
ZITHROMAX |
2F027
|
PFIZER LABORATORIES DIV OF PFIZER INC |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
ZITHROMAX CAPSULES |
2F027
|
PFIZER LABORATORIES DIV OF PFIZER INC |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
P |
U |
1 |
A |
$70.10 |
PG |
|
C2201X- |
Oct-01-1997 |
H |
| DF |
S9M |
H |
|
P |
U |
1 |
F |
$70.10 |
PG |
|
------- |
Oct-01-1997 |
H |
| DN |
S9M |
H |
|
P |
U |
1 |
N |
$70.10 |
PG |
|
9L----- |
Oct-01-1997 |
H |
| DS |
S9M |
H |
|
P |
U |
1 |
D |
$70.10 |
PG |
|
------- |
Oct-01-1997 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 18EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 18EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 18EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 18EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
CARD |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
3 |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
6.000 |
| FEAT |
SPECIAL FEATURES |
18 CAPSULES PER PG; 250 MG AZITHROMYCIN ACTIVE INGREDIENT |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| THPE |
THERAPEUTIC EQUIVALENT |
ZITHROMAX BY PFIZER LABORATORIES |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Nov-07-1997 |
3 |
H |
|
|
|
|
| FSKX |
|
Nov-07-1997 |
3 |
H |
|
|
|
|
| N9LM |
|
Nov-07-1997 |
3 |
H |
|
|
HD |
|
|